Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.

Rapp SR, Espeland MA, Shumaker SA, Henderson VW, Brunner RL, Manson JE, Gass ML, Stefanick ML, Lane DS, Hays J, Johnson KC, Coker LH, Dailey M, Bowen D; WHIMS Investigators.

JAMA. 2003 May 28;289(20):2663-72.

PMID:
12771113
2.

The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.

Gurney EP, Nachtigall MJ, Nachtigall LE, Naftolin F.

J Steroid Biochem Mol Biol. 2014 Jul;142:4-11. doi: 10.1016/j.jsbmb.2013.10.009. Epub 2013 Oct 27. Review.

PMID:
24172877
3.

Hormone therapy, dementia, and cognition: the Women's Health Initiative 10 years on.

Maki PM, Henderson VW.

Climacteric. 2012 Jun;15(3):256-62. doi: 10.3109/13697137.2012.660613. Review.

4.

The Women's Health Initiative Memory Study: findings and implications for treatment.

Craig MC, Maki PM, Murphy DG.

Lancet Neurol. 2005 Mar;4(3):190-4. Review.

PMID:
15721829
5.

New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits.

Modena MG, Sismondi P, Mueck AO, Kuttenn F, Lignières Bd, Verhaeghe J, Foidart JM, Caufriez A, Genazzani AR; TREAT.

Maturitas. 2005 Sep 16;52(1):1-10. Review.

PMID:
15963666
7.

Postmenopausal hormone therapy and cognition.

McCarrey AC, Resnick SM.

Horm Behav. 2015 Aug;74:167-72. doi: 10.1016/j.yhbeh.2015.04.018. Epub 2015 Apr 30. Review.

8.
9.

Alzheimer's disease, menopause and the impact of the estrogenic environment.

Pines A.

Climacteric. 2016 Oct;19(5):430-2. doi: 10.1080/13697137.2016.1201319. Epub 2016 Jun 21. Review.

PMID:
27327261
10.

Changing concepts: Menopausal hormone therapy and breast cancer.

Chlebowski RT, Anderson GL.

J Natl Cancer Inst. 2012 Apr 4;104(7):517-27. doi: 10.1093/jnci/djs014. Epub 2012 Mar 16. Review.

11.

Hormone replacement therapy for cognitive function in postmenopausal women.

Lethaby A, Hogervorst E, Richards M, Yesufu A, Yaffe K.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD003122. doi: 10.1002/14651858.CD003122.pub2. Review.

PMID:
18254016
12.

Postmenopausal hormone therapy and the risks of coronary heart disease, breast cancer, and stroke.

Prentice RL.

Semin Reprod Med. 2014 Nov;32(6):419-25. doi: 10.1055/s-0034-1384624. Epub 2014 Oct 16. Review.

13.

Cognitive changes after menopause: influence of estrogen.

Henderson VW.

Clin Obstet Gynecol. 2008 Sep;51(3):618-26. doi: 10.1097/GRF.0b013e318180ba10. Review.

14.

Hormone replacement therapy to maintain cognitive function in women with dementia.

Hogervorst E, Yaffe K, Richards M, Huppert FA.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD003799. doi: 10.1002/14651858.CD003799.pub2. Review.

PMID:
19160224
15.

The Heart and Estrogen/Progestin Replacement Study: what have we learned and what questions remain?

Wells G, Herrington DM.

Drugs Aging. 1999 Dec;15(6):419-22. Review.

PMID:
10641952
16.

Hormones and bone health in postmenopausal women.

Lindsay R.

Endocrine. 2004 Aug;24(3):223-30. Review.

PMID:
15542889
17.

Menopausal hormone therapy and cancer: changing clinical observations of target site specificity.

Chlebowski RT, Anderson GL.

Steroids. 2014 Nov;90:53-9. doi: 10.1016/j.steroids.2014.06.001. Epub 2014 Jun 6. Review.

18.

Breast Cancer and Menopausal Hormone Therapy by Race/Ethnicity and Body Mass Index.

Chlebowski RT, Anderson GL, Aragaki AK, Prentice R.

J Natl Cancer Inst. 2015 Nov 5;108(2). pii: djv327. doi: 10.1093/jnci/djv327. Print 2016 Feb. Review.

19.

Action of estrogens in the aging brain: dementia and cognitive aging.

Henderson VW.

Biochim Biophys Acta. 2010 Oct;1800(10):1077-83. doi: 10.1016/j.bbagen.2009.11.005. Epub 2009 Nov 12. Review.

PMID:
19913598
20.

Supplemental Content

Support Center